Received Jun 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
headache; sinus pressure; watery eyes; bodyaches; ears pain; chills; sinus infection; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of headache in a patient who received Herpes zoster (Shingrix) for prophylaxis. In MAY-2025, the patient received the 1st dose of Shingrix. In MAY-2025, less than a week after receiving Shingrix, the patient experienced headache (Verbatim: headache), sinus pressure (Verbatim: sinus pressure), watering eyes (Verbatim: watery eyes), general body pain (Verbatim: bodyaches), ear pain (Verbatim: ears pain), chills (Verbatim: chills) and sinus infection (Verbatim: sinus infection). The outcome of the headache, sinus pressure, watering eyes, general body pain, ear pain, chills and sinus infection were not resolved. It was unknown if the reporter considered the headache, sinus pressure, watering eyes, general body pain, ear pain, chills and sinus infection to be related to Shingrix. It was unknown if the company considered the headache, sinus pressure, watering eyes, general body pain, ear pain, chills and sinus infection to be related to Shingrix. Additional Information: GSK Receipt Date: 31-MAY-2025 This case was reported by a patient via (Shingrix Chatbot) interactive digital media. The reporter stated that he/she had first dose of Shingrix vaccine two days ago and experienced side effects headache, sinus pressure, watery eyes, body aches, chills, no fever, headache and ears pain. The patient stated he/she do not know if it is sinus infection or injection side effect its been 2 days since received first dose The patient enquired how long do side effect last